Noble James
SEC insider (Form 3/4/5 filer). CIK 0001388000. Director at LAVA Therapeutics NV (LVTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Nov 13, 2025. Located in UTRECHT, P7.
Companies Noble James has filed insider reports for
- LAVA Therapeutics NV (LVTX): Director
Noble James
CIK: 0001388000
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LVTX
LAVA Therapeutics NV
Director